Ricardo Cordero

Aspivix is a medical device company in women’s health, based in Switzerland and in California, developing next-generation devices for gynecology. Our flagship product, carevix®, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. Recognized as one the Best Inventions 2024 by TIME, carevix® is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. carevix® study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the pain by up to 73% and the bleeding by up to 83% in IUD insertions. More than 120 million women worldwide have procedures using the antiquated single-tooth tenaculum, an instrument invented over a century ago, without consideration of a womans anatomy or pain, and yet it is still considered to be the standard of care in gynecology. At Aspivix, we think women deserve more. We are driven by our vision to make gynecology modern.

HEMEX is a CRO providing clinical services to European biotech and medtech companies, assisting them throughout the clinical development process to ensure that products reach the market swiftly. Located in the Basel region, a major life sciences hub, and with offices in Germany, Benelux, and the United States, we are well positioned to serve small and medium enterprises (SMEs) with multinational clinical projects. The comprehensive package of services we provide includes clinical operations, quality management, regulatory guidance, grant writing services, and fundraising options. At HEMEX, we guarantee fast and clear communication, local accessibility, and transparency to meet the objectives of our clients.

Opterion Health is focused to bring innovation to dialysis and foster peritoneal dialysis (PD). The company aims to improve the quality of life for patients as well as their loved ones and to possibly increase the survival rates of people who suffer from chronic kidney disease (CKD). Opterion Health was founded in 2012 by healthcare experts. The Company, based in Switzerland, is one of the few research-driven companies developing a novel PD solution. Opterion Health is privately held and financed by Angel Investors. The new Opterion dialysis solution is the first innovation in PD in the last two decades and will not only improve patients’ well-being by offering flexibility at work and at home, but also reduce dialysis-related healthcare costs. The new PD solution is glucose-free, considerably decreasing metabolic challenges and offers an innovative dialysis option for those patients who suffer from diabetes (approx. 45% of dialysis patients). Opterion Health is a pure play PD Company with two novel approaches in development, based on known molecules. Our two-fold approach will increase the medical utility of PD by offering a better osmotic driver (ODR) and – possibly in combination – a biocompatibility-enhancing agent (BCA).

zai focuses on highest quality and the reduction to the essentials. the result is products which radiate an unparalleled aura with their simple aesthetics. And offer a unique skiing experience: easier, more joyful, with more perfection.

zai ist der Traum vom perfekten Ski. Vom Ski, der keine Kompromisse eingeht. Weder beim Material noch bei der Konstruktion. Und der deshalb ein ganz neues Fahrerlebnis bietet: leichter, freudvoller, vollendeter. zai ist Rätoromanisch. Und steht für zäh. Oder noch besser «tough». Sursilvan heisst die Sprache, die zwischen Trin und Oberalp gesprochen wird. Also auch in Disentis, wo die zai-Ski gebaut werden. Gleich unterhalb des uralten Benediktinerklosters. zai ist die Freiheit, die sich einstellt, wenn nicht die Dinge uns, sondern wir die Dinge beherrschen. Und die Freude des Augenblicks, wenn wir ganz uns selber sind. zai ist auch eine Geisteshaltung. Die Suche nach der idealen Linie im Schnee. Die Abneigung gegen jede Form von Kompromiss. Da tut sich auch eine Geistesverwandtschaft auf mit einem ganz ähnlichen Wort aus fernöstlicher Philosophie.

BZ Bank is your point of contact when you are looking for securities trading services and advisory services with respect to equity investments and participations. Efficient and straightforward operations, trust based relationships and high quality and moral concepts are our strong points. Client needs are always at the heart of all our efforts.

Aspivix is a medical device company in women’s health, based in Switzerland and in California, developing next-generation devices for gynecology. Our flagship product, carevix®, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. Recognized as one the Best Inventions 2024 by TIME, carevix® is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. carevix® study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the pain by up to 73% and the bleeding by up to 83% in IUD insertions. More than 120 million women worldwide have procedures using the antiquated single-tooth tenaculum, an instrument invented over a century ago, without consideration of a womans anatomy or pain, and yet it is still considered to be the standard of care in gynecology. At Aspivix, we think women deserve more. We are driven by our vision to make gynecology modern.

HEMEX is a CRO providing clinical services to European biotech and medtech companies, assisting them throughout the clinical development process to ensure that products reach the market swiftly. Located in the Basel region, a major life sciences hub, and with offices in Germany, Benelux, and the United States, we are well positioned to serve small and medium enterprises (SMEs) with multinational clinical projects. The comprehensive package of services we provide includes clinical operations, quality management, regulatory guidance, grant writing services, and fundraising options. At HEMEX, we guarantee fast and clear communication, local accessibility, and transparency to meet the objectives of our clients.

Opterion Health is focused to bring innovation to dialysis and foster peritoneal dialysis (PD). The company aims to improve the quality of life for patients as well as their loved ones and to possibly increase the survival rates of people who suffer from chronic kidney disease (CKD). Opterion Health was founded in 2012 by healthcare experts. The Company, based in Switzerland, is one of the few research-driven companies developing a novel PD solution. Opterion Health is privately held and financed by Angel Investors. The new Opterion dialysis solution is the first innovation in PD in the last two decades and will not only improve patients’ well-being by offering flexibility at work and at home, but also reduce dialysis-related healthcare costs. The new PD solution is glucose-free, considerably decreasing metabolic challenges and offers an innovative dialysis option for those patients who suffer from diabetes (approx. 45% of dialysis patients). Opterion Health is a pure play PD Company with two novel approaches in development, based on known molecules. Our two-fold approach will increase the medical utility of PD by offering a better osmotic driver (ODR) and – possibly in combination – a biocompatibility-enhancing agent (BCA).

zai focuses on highest quality and the reduction to the essentials. the result is products which radiate an unparalleled aura with their simple aesthetics. And offer a unique skiing experience: easier, more joyful, with more perfection.